Titelia

Holdings of Defilade Capital Management, L.P.

30 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 52.8 % of the equity sleeve

Sector breakdown

  • Health care 38.3 %
  • Unattributed 61.7 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 98.0 %
  • DK 1.7 %
  • GB 0.4 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US28695.1M $97.98 %
2DK111.9M $1.67 %
3GB12.5M $0.35 %

Positions

RankCompanySharesValueWeight
1Zimmer Biomet Holdings Inc 579,16152.4M $
2Henry Schein Inc 624,03746M $
3Becton Dickinson & Co 279,21043.9M $
4PTC Therapeutics Inc 376,16541.1M $
5Dexcom Inc 538,76233.8M $
6ICU Medical Inc 254,29132.8M $
7Insmed Inc 194,90931.9M $
8Intuitive Surgical Inc 67,68131.2M $
9Revolution Medicines Inc 315,97230.7M $
10Globus Medical Inc 354,35030.5M $
11Neurocrine Biosciences Inc 209,93227.7M $
12Denali Therapeutics Inc 1,359,96926.1M $
13PACS Group Inc 604,18025.6M $
14Olema Pharmaceuticals Inc 1,504,53622.4M $
15Elanco Animal Health Inc 931,12122.3M $
16Pfizer Inc 1,464,12919.4M $
17Eli Lilly & Co 20,69619M $
18Lantheus Holdings Inc 249,40118.9M $
19Integer Holdings Corp 213,02718.7M $
20Biogen Inc 96,28917.7M $
21Evommune Inc 678,58915.6M $
22Tandem Diabetes Care Inc 761,90514.6M $
23Cogent Biosciences Inc 352,59013.6M $
24Nuvalent Inc 129,95013.3M $
25Ocular Therapeutix Inc 1,487,64512.6M $
26Ascendis Pharma A/S 51,89511.9M $
27Align Technology Inc 67,33211.5M $
28Eledon Pharmaceuticals Inc 3,564,12711M $
29ORIC Pharmaceuticals Inc 842,92810.7M $
30MEREO BIOPHARMA GROUP PLC 7,558,7562.5M $